| ATA | American Thyroid Association |
| Tg-Abs | Anti-thyroglobulin antibodies |
| CRM | Certified reference material |
| ECLIA | Chemiluminescent enzyme immunoassay |
| CID | Collision-induced dissociation |
| DTC | Differentiated thyroid carcinoma |
| DELFIA | Dissociation-enhanced lanthanide fluorescent immunoassay |
| DBS | Dried blood spot |
| DBS-MS | Dried blood spot MS-based tool |
| ELISA | Enzyme-linked immunosorbent assay |
| ETA | European Thyroid Association |
| FSP | FSPDDSAGASALLR |
| Hct | Hematocrit |
| HAs | Heterophile antibodies |
| HAMAs | Human anti-mouse antibodies |
| IMAs | Immunoassays |
| IEMA | Immunoenzymometric assay |
| iqDBS | Internal quantitative DBS |
| IS | Internal standard |
| µLC–MS/MS | LC-MS/MS system operating at microliter/minute flow rates |
| LOD | Limit of detection |
| LOQ | Limit of quantification |
| LLOQ | Lower limit of quantification |
| LC-MS/MS | Liquid chromatography tandem mass spectrometry |
| LC-QqQ | Liquid chromatography triple quadrupole |
| m/z | Mass-to-charge ratio |
| MRM | Multiple reaction monitoring |
| PTC | Papillary thyroid cancer |
| RIAs | Radioimmunoassays |
| 2nd-RIAs | Second generation RIAs |
| SISCAPA® | Stable isotope standards captured by anti-peptide antibodies |
| Tg-DBS | Tg analyses on DBS |
| Tg-DBS-ELISA | Tg-DBS enzyme-linked immunosorbent assay |
| Tg-2nd-IMAs | Tg-second generation IMAs |
| TDM | Therapeutic drug monitoring |
| Tg | Thyroglobulin |
| TSH | Thyroid-stimulating hormone |
| TRACE | Time-resolved amplified cryptate emission |
| UHPLC | Ultrahigh-performance liquid chromatography |
| VIF | VIFDANAPVAVR |